Evaluation of the immune system response to Diphtheria and Tetanus vaccination in HIV positive patients
Not Applicable
- Conditions
- HIV AIDS.Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases
- Registration Number
- IRCT201211204076N8
- Lead Sponsor
- Resaerch Deputy tehran university of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
age above 18 and under 65 years; accepting the consent form and unresponsive to previous vaccination
Exclusion criteria: pregnancy; age under 18 and above 65 years and positive antibody for Diphteria and Tetanus.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DT Antibody. Timepoint: Before vaccination, 1 and 6 month after vaccination. Method of measurement: Serum antibody level.
- Secondary Outcome Measures
Name Time Method CD4 count. Timepoint: Before vaccination. Method of measurement: flowcytometery.